Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis

The purpose of this study is to determine the efficacy and safety of a single dose of 750 U of Dysport compared to placebo for the improvement in the daily incontinence episode frequency for each administration mode in subjects suffering from neurogenic detrusor overactivity following spinal cord injury or multiple sclerosis.

Related Clinical Trials